CLINICAL_TRIALS
research
· 2026-04-23
Clinical Trial Update: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Summary
A clinical trial is investigating optimized diagnostic approaches for Pneumocystis pneumonia in immunocompromised patients and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumocystis, Immunocompromised Patients | Status: RECRUITING